Abel Hall LLC’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$222K Sell
2,593
-293
-10% -$28.7K 0.04% 630
2026
Q2
$299K Buy
+2,886
New +$258K 0.05% 480
2024
Q4
– Sell
-3,353
Closed -$211K – 172
2024
Q3
$211K Sell
3,353
-163
-5% -$9.5K 0.14% 131
2024
Q2
$208K Buy
3,516
+119
+4% +$7.44K 0.15% 124
2024
Q1
$271K Sell
3,397
-54
-2% -$4.12K 0.2% 89
2023
Q4
$272K Buy
+3,451
New +$246K 0.23% 79

Other funds holding CVS

Abel Hall LLC's CVS Position: Q3 2026 in Review

Abel Hall LLC reduced its CVS Health (CVS) stake by 10% in Q3 2026, selling an estimated $28.7K and leaving 2,593 shares worth $222K. The position accounts for 0.04% of the portfolio, ranked #630.

Abel Hall LLC first reported a position in CVS in Q4 2023 and has held it in 6 quarters since. The position peaked at $299K in Q2 2026. 764 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • Abel Hall LLC held 2,593 shares of CVS Health worth $222K as of Q3 2026.
  • Abel Hall LLC sold 293 CVS Health shares in Q3 2026, an estimated $28.7K.
  • CVS Health made up 0.04% of Abel Hall LLC's portfolio in Q3 2026, its #630 holding.
  • Abel Hall LLC first reported a position in CVS Health in Q4 2023 and has held it in 6 quarters since.
  • Abel Hall LLC's CVS Health position peaked at $299K in Q2 2026.
  • 764 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.